Avid Bioservices Inc (CDMO)

[cjgaddy]

Dr. Thorpe, Gordon Conf. 3-11-2010. I like the venue, the company, and the little twist Dr. Thorpe added at the end of his presentation title…

Mar7-12 2010: “Antibody Biology & Engineering - from Basic Mechanisms to Antibody-Based Therapeutics” (Gordon Research Conf.), Ventura CA
3-11-10 Session VIII (7:30-9:30pm): “THERAPEUTIC ANTIBODIES”
Discussion Leader: Andrew Chan, [Senior VP of Immunology] Genentech, Inc.
• 7:30-7:45pm Andrew Chan (Genentech) "Opening remarks"
• 7:45-8:05pm Philip Thorpe (UTSW-MC), "Targeting Phosphatidylserine In The Tumor Microenvironment to Destroy Tumor Blood Vessels and Induce Tumor Immunity"
• 8:15-8:35pm Wayne Marasco (Harvard Medical School)
• 8:45-9:05pm Steve Jacobsen (Wyeth Research), "Alzheimer's disease immunotherapy from mouse to man"
http://www.grc.org/programs.aspx?year=2010&program=antibody

ORIGIN, PURPOSE & COMMITMENT OF THE CONFERENCES…
“The Gordon Research Conferences (GRCs) were initiated by Dr. Neil E. Gordon, of the Johns Hopkins University, who recognized in the late 1920s the difficulty in establishing good, direct communication between scientists, whether working in the same subject area or in interdisciplinary research. The GRCs promote discussions and the free exchange of ideas at the research frontiers of the biological, chemical & physical sciences. Scientists with common professional interests come together for a full week of intense discussion & examination of the most advanced aspects of their field. These Conferences provide a valuable means of disseminating information and ideas in a way that cannot be achieved through the usual channels of communication - publications and presentations at large scientific meetings.”
http://www.grc.org/about.aspx

= = = = = = = = = = =
EXECUTIVE PROFILE
Andrew C. Chan MD, PhD
…serves as Senior VP of Immunology of Genentech Inc. Dr. Chan is responsible for overseeing research programs focused on the role of the immune system in cancer and various immunological disorders. He served as VP, Research-Immunology of Genentech, Inc. since July 17, 2003. He continued to supervise Genentech's immunology research program for the treatment of immune-mediated and inflammatory disorders. Dr. Chan's laboratory is currently ...
http://tinyurl.com/yjfqmfz